Shanghai, China

Chenxi Liang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenxi Liang. Retrieved from https://idiyas.com/inventor/chenxi-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Chenxi Liang

Introduction

Chenxi Liang is an accomplished inventor based in Shanghai, China. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions.

Latest Patents

One of her notable patents is titled "Methods for treating metastasis with cathepsin C inhibitors." This patent outlines methods for treating cancer metastasis using a pharmaceutical composition that includes an effective amount of a cathepsin C (CTSC) inhibitor. The CTSC inhibitor, in some embodiments, is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, such as brensocatib. The treatment methods described in the patent aim to inhibit, slow, or reverse the progression of metastasis. Additionally, the methods may involve reducing neutrophil infiltration and/or the formation of neutrophil extracellular traps (NETs). Chenxi Liang holds 1 patent in this area.

Career Highlights

Chenxi Liang is affiliated with the Chinese Academy of Sciences, where she conducts her research. Her work focuses on developing innovative solutions for cancer treatment, particularly in addressing the challenges posed by metastasis.

Collaborations

Some of her coworkers include Guohong Hu and Yansen Xiao, who contribute to her research efforts and collaborative projects.

Conclusion

Chenxi Liang's innovative work in cancer treatment exemplifies the potential of pharmaceutical compositions to address complex medical challenges. Her contributions are paving the way for advancements in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…